Published in Nutr Metab (Lond) on October 12, 2010
Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med (2012) 2.20
Potential viral pathogenic mechanism in human type 1 diabetes. Diabetologia (2014) 0.88
Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders. Evol Med Public Health (2013) 0.85
Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). PLoS One (2015) 0.83
The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups. Front Physiol (2014) 0.81
Support for the Microgenderome: Associations in a Human Clinical Population. Sci Rep (2016) 0.80
The Crosstalk between the Gut Microbiota and Mitochondria during Exercise. Front Physiol (2017) 0.76
Beneficial Properties of Probiotics. Trop Life Sci Res (2016) 0.75
Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome. Neurogastroenterol Motil (2015) 0.75
A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)? J Clin Med (2016) 0.75
Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in Apc(Min/+) mice. Sci Rep (2017) 0.75
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Retracted Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science (2009) 10.76
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50
A community-based study of chronic fatigue syndrome. Arch Intern Med (1999) 6.04
Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One (2010) 4.66
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology (2010) 4.18
Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology (2010) 3.64
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology (2002) 3.11
Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol (1992) 3.05
Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med (2000) 2.89
Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect Immun (1974) 2.61
Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. Pharmacol Rep (2007) 2.40
Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut (1983) 2.39
Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care (1996) 2.08
The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology (2006) 2.08
Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J (2010) 2.06
Prenatal stress alters bacterial colonization of the gut in infant monkeys. J Pediatr Gastroenterol Nutr (2004) 2.02
A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun (2010) 1.95
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol (2003) 1.92
Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol (2010) 1.90
Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain (2009) 1.80
Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun (2008) 1.78
A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog (2009) 1.74
Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology (2006) 1.66
Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis (1991) 1.64
Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil (2004) 1.63
An examination of the working case definition of chronic fatigue syndrome. Am J Med (1996) 1.59
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther (2007) 1.58
Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol (1999) 1.57
Plasma cytokines in women with chronic fatigue syndrome. J Transl Med (2009) 1.55
A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res (2003) 1.48
Immunological aspects of chronic fatigue syndrome. Autoimmun Rev (2008) 1.42
Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry (1998) 1.37
New pathophysiological insights and modern treatment of IBD. J Gastroenterol (2010) 1.31
Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med (2009) 1.31
Bench-to-bedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care. Crit Care (2009) 1.31
Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol Motil (1998) 1.29
Irritable bowel syndrome: towards biomarker identification. Trends Mol Med (2009) 1.29
The enteric nervous system: normal functions and enteric neuropathies. Neurogastroenterol Motil (2008) 1.29
Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr Rheumatol Rep (2007) 1.28
To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med (2006) 1.24
Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut (1998) 1.24
Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol (2006) 1.21
Neuroinflammation in inflammatory bowel disease. J Neuroinflammation (2010) 1.18
Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav (1998) 1.15
Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology (2005) 1.12
Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol (2010) 1.10
Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil (2008) 1.10
Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med (2005) 1.10
Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome. Neuro Endocrinol Lett (2009) 1.09
Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol (2002) 1.08
Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther (2010) 1.08
Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy (2003) 1.06
Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med (2010) 1.06
Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig (2009) 1.04
Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults. Ann Intern Med (1993) 1.03
A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res (2002) 1.03
Catecholamines modulate Escherichia coli O157:H7 adherence to murine cecal mucosa. Shock (2003) 1.02
Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett (2009) 1.02
Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil (2010) 1.00
Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav Immun (2007) 0.99
Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypotheses (2003) 0.97
Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J Med Virol (2010) 0.96
Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett (2009) 0.96
Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord (2006) 0.96
Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome. In Vivo (2009) 0.96
Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. In Vivo (2009) 0.94
Axonal necrosis of enteric autonomic nerves in continent ileal pouches. Possible implications for pathogenesis of Crohn's disease. Ann Surg (1993) 0.93
Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol (N Y) (2010) 0.92
Glutamine supplemented parenteral nutrition prevents intestinal ischemia- reperfusion injury in rats. World J Gastroenterol (2004) 0.91
Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function. Brain Res Brain Res Rev (1998) 0.91
Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J Clin Virol (2006) 0.89
Effects of crowding and heat stress on intestinal flora, body weight gain, and feed efficiency of growing rats and chicks. Nihon Juigaku Zasshi (1983) 0.84
Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutr J (2009) 0.83
Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments. J Clin Pathol (2006) 0.81
The effect of dietary glutathione and coenzyme Q10 on the prevention and treatment of inflammatory bowel disease in mice. Int J Vitam Nutr Res (2004) 0.77
Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med (2009) 3.35
Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol (2013) 1.23
Neuroinflammation in inflammatory bowel disease. J Neuroinflammation (2010) 1.18
Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav (2012) 1.06
The emerging role of dietary fructose in obesity and cognitive decline. Nutr J (2013) 1.05
Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med (2011) 0.96
Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med (2010) 0.92
Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review. BMC Res Notes (2010) 0.85
Schizophrenia genomics and proteomics: are we any closer to biomarker discovery? Behav Brain Funct (2009) 0.82
The impact of prescribed psychotropics on youth. Clin Pract Epidemiol Ment Health (2007) 0.80
Chronic traumatic encephalopathy: the dangers of getting "dinged". Springerplus (2012) 0.80
Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J Transl Med (2011) 0.77